Can Genomics Stop the World’s Leading Cause of Death? Read the article on Illuminas website: Can Genomics Stop the World’s Leading Cause of Death? (illumina.com)
“The Kühne Foundation has dedicated itself to education and research as well as science in the field of logistics – including humanitarian logistics. Another focus is our medicine funding through research, therapy and training for allergology and gebirgsklinik, a renowed rehabilitation hospital, and various research institutions. In the area of culture, we support leading opera […]
To access the article and supplemental materials, please click on the buttons below. Article Supplement (PDF) Supplement (Rmd) To access the full article in the Scientometrics Journal, please click on the button below. Epub ahead of print
The scientific network in Davos is growing.
Are cardiac infarctions hereditary? Davos and Hamburg searching for disease genes. Two years ago, a study involving 9000 persons has been initiated in close collaboration between the Universitätsklinikum Hamburg-Eppendorf and Cardio-CARE in Davos. 8000 of these persons have been selected at random, 1000 persons were diagnosed with cardiovascular diseases. The goal of this project is to find mutations in the genome which lead to cardiovascular diseases.
The registration for the Summer School on Genetic Epidemiology is open.
Mild COVID-19 infections left non-mild traces on multiple organs: lessons from the Hamburg City Health Study
The pandemic of COVID-19 has caused millions of infections worldwide and the numbers are skyrocketing due to the quick-spreading omicron variant this winter.
Key priority of the Kühne Foundation is the support for training, further education as well as research and science in the area of logistics. This also includes Humanitarian Logistics and a project concentrating on free global trade.
Professor Andreas Ziegler, as the co-inventor, submitted the computing device for estimating the probability of myocardial infarction to European Patent Office. This work is in collaboration with the University Heart & Vascular Center Hamburg (UHZ).
On January 1, 2020, Prof. Dr. Andreas Ziegler started as scientific director and CEO of Cardio-CARE. He is a board-certified biostatistician and epidemiologist. His research activities include Genetic Epidemiology, clinical trials for medical devices and artificial intelligence. Detailed information could be found in his CV.